Panacea Biotec (BOM:531349) YoY EBITDA Growth : -74.88% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Panacea Biotec's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -74.88%.

Panacea Biotec's EBITDA per Share for the three months ended in Mar. 2024 was ₹1.23.

Panacea Biotec YoY EBITDA Growth Historical Data

The historical data trend for Panacea Biotec's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec YoY EBITDA Growth Chart

Panacea Biotec Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

-75.60

87.98

1,833.68

-96.63

-26.33

Panacea Biotec Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															-98.19	158.87	-92.92	-74.09	-74.88

Panacea Biotec YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Panacea Biotec's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(6.783	-	9.207)	/	\| 9.207 \|
=	-26.33 %

Panacea Biotec's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(1.226	-	4.88)	/	\| 4.88 \|
=	-74.88 %

Panacea Biotec YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacea Biotec (BOM:531349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

PANACEABIO:India

Address

Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044

Website

https://www.panaceabiotec.com

Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (BOM:531349) Headlines

No Headlines